HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.

Abstract
IL-1β and IL-18 are pro-inflammatory cytokines that are linked to inflammation. Activation of the NOD-like receptor protein 3 (NLRP3) inflammasome is involved in the maturation and secretion of IL-1β and IL-18 and, thus, plays a key role in the pathogenesis of many inflammatory conditions, including multiple sclerosis (MS). OLT1177™ (Dapansutrile) is a newly developed drug that is safe in humans and inhibits specifically the NLRP3 inflammasome. In the present study, we investigated whether OLT1177 exerts therapeutic effects in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. We found that EAE mice fed an OLT1177-enriched diet prophylactically were significantly protected against functional deficits and demyelination in the spinal cord. We also demonstrated that prophylactic oral administration of OLT1177 led to marked reduction (~2- to 3-fold) in the protein levels of IL-1β and IL-18, as well as, IL-6 and TNFα, in the spinal cord of EAE mice. Moreover, prophylactic oral administration of OLT1177 significantly attenuated the infiltration of CD4 T cells and macrophages in the spinal cord. We also demonstrated that oral administration of OLT1177, starting at disease onset, resulted in significant amelioration of the clinical signs of EAE. Overall, these first data suggest that OLT1177 could have clinical benefit for the treatment of MS in humans.
AuthorsAlba Sánchez-Fernández, Damaris B Skouras, Charles A Dinarello, Rubèn López-Vales
JournalFrontiers in immunology (Front Immunol) Vol. 10 Pg. 2578 ( 2019) ISSN: 1664-3224 [Electronic] Switzerland
PMID31736980 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Sánchez-Fernández, Skouras, Dinarello and López-Vales.
Chemical References
  • Anti-Inflammatory Agents
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nitriles
  • Nlrp3 protein, mouse
  • dapansutrile
Topics
  • Administration, Oral
  • Animals
  • Anti-Inflammatory Agents (therapeutic use)
  • CD4-Positive T-Lymphocytes (drug effects, immunology)
  • Cognitive Dysfunction (drug therapy, immunology, pathology)
  • Encephalomyelitis, Autoimmune, Experimental (drug therapy, immunology, pathology)
  • Female
  • Inflammasomes (antagonists & inhibitors)
  • Macrophages (drug effects, immunology)
  • Mice, Inbred C57BL
  • NLR Family, Pyrin Domain-Containing 3 Protein (antagonists & inhibitors)
  • Nitriles (therapeutic use)
  • Spinal Cord (drug effects, immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: